Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT06841679 · RECRUITING
Trial details
- NCT number
- NCT06841679
- Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-28
- Primary completion
- 2030-09-01
- Enrollment
- 778
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.